Latest content

  • NanoTemper Technologies welcomes Andreas Schmitz as its first Chief Human Resources Officer

    NanoTemper Technologies welcomes Andreas Schmitz as its first Chief Human Resources Officer

    MUNICH, Germany, 18 May 2022 — NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, welcomes Andreas Schmitz as the first Chief Human...

    Read
  • [New] Dianthus with Spectral Shift

    Overcome your biggest challenges when characterizing PROTAC binary and ternary complexes.

    Learn how
  • Learn more about your protein expression conditions in less time with Andromeda

    Learn more about your protein expression conditions in less time with Andromeda

    Learn more about your protein expression conditions in less time with Andromeda

    Read
  • 8 Gene Therapy conferences you should attend in 2022

    8 Gene Therapy conferences you should attend in 2022

    With the first AAV-based gene therapies approved, and new gene editing strategies emerging, it’s important to stay on top of the latest topics in this therapeutic area. Here are 8 gene therapy...

    Read
  • 9 Targeted Protein Degradation conferences you don’t want to miss in 2022

    9 Targeted Protein Degradation conferences you don’t want to miss in 2022

    With so much interest and investment in target protein degradation, a lot can happen in a year. Here are 9 conferences to get up-to-date on recent progress and the latest approaches. You’ll not...

    Read
  • Ways light scattering technologies help you if you’re in gene therapy

    Ways light scattering technologies help you if you’re in gene therapy

    Read
  • [New] Prometheus Panta with SLS

    Build effective AAV vectors for gene therapy with
    high-quality stability profiling data

    Learn more
  • Four technologies to profile your AAVs

    Four technologies to profile your AAVs

    Read
  • ×

    Sign up to receive
    the latest NanoTemper news, product updates, event announcements and more

    First Name
    Last Name
    Company Name
    Country
    State
    Province
    State
    Region
    State
    Canton
    Agree to Subscribe & Privacy Policy*
    *I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

    By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
    Thank you!
    Error - something went wrong!
  • NanoTemper Technologies and PharmAI launch Proto, a free AI tool to quickly determine optimal protein labeling strategy

    NanoTemper Technologies and PharmAI launch Proto, a free AI tool to quickly determine optimal protein labeling strategy

    MUNICH/DRESDEN, April 6, 2022—NanoTemper Technologies, in partnership with PharmAI, announced the launch of Proto, a free AI-based web application that reveals the best labeling strategy to help...

    Read
  • 10 terms to help you more easily understand targeted protein degradation

    10 terms to help you more easily understand targeted protein degradation

    Targeted Protein Degradation (TPD), a relatively new therapeutic approach, is making waves by targeting otherwise ‘undruggable’ proteins. PROTACs are the best-understood protein degraders, with...

    Read
  • NanoTemper Technologies launches Spectral Shift, a breakthrough technology that changes the game for affinity-based screenings

    NanoTemper Technologies launches Spectral Shift, a breakthrough technology that changes the game for affinity-based screenings

    NanoTemper Technologies, announced today the launch of Spectral Shift technology within their Dianthus instrument, built to handle the most challenging affinity-based screenings in drug discovery....

    Read
  • Have a question?

    Contact Specialist
  • Finally tackle your most challenging affinity screenings with breakthrough Spectral Shift technology with Dianthus

    Finally tackle your most challenging affinity screenings with breakthrough Spectral Shift technology with Dianthus

    Read
  • Dianthus: Tackle your most challenging affinity screenings with breakthrough Spectral Shift technology2:30

    Dianthus: Tackle your most challenging affinity screenings with breakthrough Spectral Shift technology

    Watch
  • Journey of an mAb through IND and BLA filing

    Journey of an mAb through IND and BLA filing

    Read
  • Prometheus Panta: The new gold standard for biologics characterization1:41

    Prometheus Panta: The new gold standard for biologics characterization

    Choosing the right stability characterization tool for your biologics research is a big commitment. You’re going to be screening and optimizing lots of candidates, and you’ll need data on thermal stab

    Watch
  • NanoTemper Technologies arms gene therapy scientists with Static Light Scattering to sharpen their tool kit for development of AAVs

    NanoTemper Technologies arms gene therapy scientists with Static Light Scattering to sharpen their tool kit for development of AAVs

    SOUTH SAN FRANCISCO, Calif Feb 16 2022 — NanoTemper Technologies today announced the addition of Static Light Scattering (SLS) to their wildly successful Prometheus Panta, turning their instrument...

    Read
  • A new spectral shift-based method to characterize molecular interactions

    A new spectral shift-based method to characterize molecular interactions

    Read
  • Use stability profiling to build more effective gene therapy vectors with Prometheus Panta

    Use stability profiling to build more effective gene therapy vectors with Prometheus Panta

    Read
  • Use of self-interaction parameters derived from light scattering experiments for better developability assessment of biologic therapeutics

    Use of self-interaction parameters derived from light scattering experiments for better developability assessment of biologic therapeutics

    Read
  • How do you get reproducible data from protein characterization experiments? Try following this DIN SPEC

    How do you get reproducible data from protein characterization experiments? Try following this DIN SPEC

    Reproducibility is a key tenet of scientific research, but many pharma groups have projects that collaborate across different sites or that rely on materials prepared by other specialist...

    Read
  • How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods21:48

    How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods

    Optimizing your vectors for gene therapy is a daunting task. When developing and optimizing AAVs, concerns such as serotype, storage stability, expression method, and genetic fill level must be addres

    Watch
  • Overcome bottlenecks in viral vector manufacturing25:08

    Overcome bottlenecks in viral vector manufacturing

    The success of your gene therapy vectors is dependent on optimal formulation conditions. Finding a buffer that provides better long-term stability for AAVs is a crucial step in the process of developi

    Watch
  • loading
    Loading more...